Healthvista India Limited is the top supplier of non-hospital healthcare in India, based on revenue, the highest market share of 21% of the organized out-of-hospital healthcare industry in Fiscal 2021, the number of cities they served as of December 31, 2021, and other factors. (F&S Report as Source). Healthvista India IPO will hit the stock market in November 2022.
Table of Contents
About Healthvista India
They offer a wide variety of out-of-hospital healthcare services, including primary care, geriatric (elderly) & palliative (end-of-life) care, intensive care unit care, post-operative & post-hospitalization care, chronic care, mother & baby care, and cancer care, all at home, under their well-known brand Portea. Additionally, they sell & rent “point of care” medical equipment in addition to speciality medications.
They had opened 40 offices around India as of March 31, 2022, & had contracts in place with 63 hospitals, 80 corporations, 8 insurers, & 11 insurance third party administrators to offer outpatient healthcare services to their patients, employees, & insured clients, respectively.
To meet their patients’ needs for out-of-hospital healthcare support, they also collaborate with reputable hospital-associated physicians as well as independent physicians & other important industry thought leaders.
Workforce
By March 31, 2022, they had formed connections with 3,058 physicians & had official agreements in place with more than 14 major opinion leaders around India.
By March 31, 2022, they hired or engaged 3,123 healthcare workers, including 2,761 workers under third-party contract agreements & 362 full-time workers who were on their payroll.
They had serviced nearly 1,200,000 distinct patients (including those covered by government programs) across India between the date of their establishment & March 31, 2022, representing a wide range of ages & medical problems.
The Indian healthcare sector is projected to develop at a CAGR of 20.5% starting in 2020 to reach US$ 870 billion by 2027, up from US$ 99 billion in 2013 and US$ 257 billion in 2020, respectively.
Business Model
By assuring established and trustworthy medical practices, Healthvista India meet the expanding demand brought on by this shift from conventional hospital-based healthcare services to outpatient medical care.
With patient trust at the core of their business practices, they have worked to establish a reputation as a comprehensive, high-quality, and reliable medical care provider. They have also used technology to improve access to their services across India at greatly reduced capital costs.
They are certain that their advanced technological stack, scalable business model, and successful application of digital-hybrid initiatives will allow them to develop their operations effectively, cover more ground, and satisfy the expanding demands of the sector. They think they are well-positioned to take advantage of this expanding market potential.
Healthvista India IPO
Healthvista India Limited, headquartered in Mumbai has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of 200 Crore and 56,252,654 Equity Shares on 29 June 2022.
The offer includes a fresh issue of INR 200 Crore and there is offer for sale (OFS) of 56,252,654 equity shares by the promoters mentioned in the DRHP. They are looking for a Pre-IPO placement INR 40 Crores in this issue.
-
- Initial Public Offering
They are now waiting for approval from Securities and Exchange Board of India(SEBI) to float the initial public offering (IPO) in the market.
Financials Trends
| Particulars | For the year/period ended ( in Cr.) | ||||
|---|---|---|---|---|---|
| 31-Dec-21 | 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | ||
| Total Assets | 101.48 | 96.01 | 97.66 | 122.39 | |
| Total Revenue | 119.11 | 130.39 | 162.06 | 149.48 | |
| Loss After Tax | (34.86) | (37.02) | (48.01) | (71.76) | |
Basic and Diluted Earnings Per Share
| Financial Period | Basic EPS (in INR) | Diluted EPS (in INR) | Weight |
| Financial Year 2021 | (5.88) | (5.88) | 3 |
| Financial Year 2020 | (7.63) | (7.63) | 2 |
| Financial Year 2019 | (11.39) | (11.39) | 1 |
| Weighted Average | (7.38) | (7.38) | |
| 31 Dec 2021 | (4.87) | (4.87) |
Objects of the Issue
- Prepayment / repayment of all or a portion of the outstanding borrowings of the company to be availed on consolidated basis.
- To meet common corporate objectives.
Basis of the offer
- Industry tailwinds – From $6.03 billion in 2021 to $15.87 billion in 2027, India’s out-of-hospital health care market is predicted to quadruple in size, increasing at a CAGR of 17% during that time, while the organized sector will expand at a rate of 32% CAGR.
- Brand of outpatient treatment with the broadest geographic reach and most established business ties to the Indian healthcare industry.
- Offering patients a wide range of options encourages customer loyalty throughout the course of their lifetime, providing numerous revenue streams and rising wallet share.
- Thorough clinical practices and in-depth medical knowledge are required to provide high-quality healthcare. Ability to recruit, develop, and keep top-notch medical staff.
- Financial stability and increased profitability.
- Seasoned and entrepreneurially motivated leadership group.
Healthvista India Peer Comparison
In India, there are no publicly traded businesses that operate in a similar industry as their Company. As a result, it is impossible to compare their company to others in its industry.
Healthvista India IPO Details
| IPO Opening Date | November 2022 |
| IPO Closing Date | November 2022 |
| Issue Type | Book Building |
| Face Value | 1 per share |
| IPO Price | 0 to 0 per equity share |
| Market Lot | – |
| Min Amount | – |
| Listing At | BSE, NSE |
| Issue Size | – |
| Fresh Issue | 200 Crore |
| Offer for Sale | 56,252,654 Equity Shares |
Healthvista India IPO Date
Healthvista India Limited IPO opening date is November 2022, and the closing date is November 2022. The Healthvista India issue may list in November 2022.
| IPO Opening Date | November 2022 |
| IPO Closing Date | November 2022 |
| Basis of Allotment Date | November 2022 |
| Initiation of Refunds | November 2022 |
| Credit of Shares to Demat Account | November 2022 |
| IPO Listing Date | November 2022 |
Basis of Allotment
| Type | % of Offer | Basis of Allotment |
|---|---|---|
| Qualified Institutional Buyer | 75 |
Roughly equivalent
|
| Non Institutional Investor | 15 |
Roughly equivalent
|
| Retail | 10 | Minimum 1 lot based on availability |
Healthvista India India Limited IPO Status
Allotment of equity stocks subject to the Fresh Issue and transfer of the Promoter Selling Shareholders’ OFS Stocks to the winning Bidders subject to the Offer for Sale. Nevertheless, the status of the allotment has yet to be revealed.
Here, you can find the Allotment Status of Healthvista India IPO.
Healthvista India IPO GMP
Healthvista India Limited IPO Grey Market Premium is 0. You can check out GMP of Other IPOs on below Links:
| Date | GMP (in Rs) | Subject to Sauda | Kostak (in Rs) |
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 | |||
| November 2022 |
Check Out the GMP of all Other IPOs
Healthvista India Limited IPO Review
Healthvista India Limited IPO review will depend on the price band which will be announced after SEBI approval. Whenever it will be announced we will update you regarding review of Healthvista India IPO is good or bad.
Healthvista India Limited IPO Risk
- They face a variety of operational & legal risks because of how their healthcare services are run. They are particularly vulnerable to the hazards that come with caregiving accidents.
- Risks associated with managing personal information, particularly medical data, could be presented to them.
- They depend heavily on their healthcare professionals, & if they are unable to attract and keep these people, it will have a serious impact on their business.
- Their success depends on the demand for outpatient medical treatment, which is influenced by patient choices, the state of the economy, and societal variables.
- They run the risk of having a materially negative impact on their business if they are unable to retain connections with specific stakeholders in their revenue generating pipeline.
Other Threats
- Failure of their internal information technology systems or those of their outside technology service providers may compromise their ability to conduct business.
- The COVID-19 pandemic may have a severe impact on their business as a healthcare provider and will likely continue to have a negative influence on their operations.
- They are dependent on outside suppliers, vendors, and subcontractors who might abandon their agreements with them.
- They run the risk of negatively affecting their business, financial health, & profitability if they don’t successfully negotiate favorable terms with their vendors or suppliers, or if they don’t pass on any cost increases to their customers.
- They are dependent on a number of critical employees, particularly their senior management & other key staffs of the company.
Healthvista India Limited IPO Brokerage views
Once the dates will be announced we will update the views of different brokerage firms regarding this IPO. Here is the views of different stock brokers regarding this Healthvista India IPO:
- Yes Securities : Not Updated
- Choice Brokering: Not Updated
- Axis Securities: Not Updated
- IIFL Securities: Not Updated
- Trade swift: Not Updated
- Anand Rathi : Not Updated
- ICICI Securities: Not Updated
Healthvista India Limited IPO Subscription Status
| Date | Day | QIB | NII | Retail | Employees | Total Subscription |
| November 2022 | 1 | |||||
| November 2022 | 2 | |||||
| November 2022 | 3 |
Healthvista India Limited Management
Meena Ganesh, Ganesh Krishnan, & Vaibhav Tewari, the company’s co-founders, founded Portea in 2013 with the goal of offering top-notch outpatient healthcare services, such as nursing, lab services, consultation, post-operative care procedures, & the provision of medical equipment, through an operational lease.
Their co-founders have a diverse range of skills across several industries thanks to their combined experience spanning several decades. TutorVista Global Private Limited, Customer Asset.com Private Limited, & e4e Business Solutions India Private Limited are just a few of the businesses its co-founders have worked on (formerly, iSeva Systems Private Limited).
Based on their own struggles to access post-hospitalization care in Bengaluru despite its advanced healthcare system, their co-founders built their company on a basis of talent, trust, technology, service, & caring.
Digital Infrastructure
They use their in-house, custom-built proprietary technology stack to deliver hybrid care to patients, resulting in cost-effective, dependable, and high-quality clinical outcomes in the convenience of their homes.
With the use of third party monitoring technologies and 24/7 remote monitoring, their digital products enable them to effectively track patients’ medical conditions, collect medical data in real-time, and communicate with patients and on-site staff online.
Additionally, they are able to scale their activities across numerous locations with the help of their technical infrastructure.
Healthvista India Limited‘ Promoters
- Accel Growth III Holding (Mauritius) Limited
- Accel India III (Mauritius) Limited
- Accel India V (Mauritius) Limited
- Meena Ganesh
- Ganesh Krishnan
- CRM Holdings Private Limited
Principal Shareholder’s Holding
| Pre Issue Share Holding | 48.76% |
| Post Issue Share Holding |
Healthvista India Limited Prospectus
Contact Details
Healthvista India Limited
No.69/B, 1st Cross, 1st Stage,
Domlur Layout, Bengaluru 560 071,
Karnataka, India
Tel: + 91 80 4553 4500
E-mail: [email protected]
Website: www.portea.com
Registrar
Link Intime India Private Limited
C-101, 1st Floor, 247 Park,
L.B.S. Marg, Vikhroli (West),
Mumbai 400 083, Maharashtra, India
Telephone: +91 (22) 4918 6200
E-mail : [email protected]
Website: www.linkintime.co.in
Lead Manager(s)
- SBI Capital Markets Limited
- IIFL SECURITIES LIMITED
- JM FINANCIAL LIMITED
We hope we are able to answer all your questions about Healthvista India IPO. If you don’t have a Demat account, open it now with Zerodha best trading app of India.
Disclaimer
The reference of IPO Grey Market Premium (IPO GMP) is only valid for the date specified in the header.
On the IPO Grey Market, we do not purchase or sell IPO forms.
The Kostak Rate is the profit earned by selling an IPO application (in an off-market transaction) to somebody else before the issue is allotted or listed.
Do not subscribe to an IPO based solely on the premium price, as it may alter at any time before to the listing. Only consider the fundamentals of the companies when subscribing.
The GMP rates for IPOs are based on market intelligence. Please keep in mind that these IPO GMP rates may vary by geography and market.
Note:
Profit must do not engage in grey market trading or facilitate the purchase or sale of IPO forms. We don’t endorse such activities at all. We are sticky against such activities & never advise anyone to trade in grey market at all.
FAQ
Healthvista India Limited IPO Opening Date?
Healthvista India Limited IPO will open in November 2022.
Healthvista India Limited IPO Listing Date?
Healthvista India Limited IPO will list in November 2022.
Healthvista India IPO GMP Today?
Healthvista India IPO Grey Market Premium is INR 0 .
Healthvista India Limited IPO Allotment Date?
Healthvista India Limited IPO basis of allotment will be in November 2022.
Lot size for Healthvista India Limited IPO?
Lot size for Healthvista India Limited IPO is 0.
